Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology

doi:10.4251/wjgo.v9.i7.293

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9789)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

742

WORD

219

HTML

5071

Tables (1-2)

270

Sum=6302

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

665

Download

1104

Sum=1769

Publishing Process of This Article

Item

Count

Browse

860

Download

858

Sum=1718

Jul 15, 2017 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (50)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Jul 15, 2017; 9(7): 293-299
Published online Jul 15, 2017. doi: 10.4251/wjgo.v9.i7.293

Table 1 Tumor-infiltrating lymphocytes associated with the prognosis of gastric cancer

Ref.	Sample size	Patient group	Location	Criteria (cut-off)	Prognostic role
Kang et al[15]	120	EBVaGC	Stromal	High infiltration	Decreased DFS and RFS
Grogg et al[16]	110	G	Intratumoral	High infiltration	Increased CSS
Lee et al[17]	220	G	Intratumoral	High density	Increased OS

EBVaGC: Epstein-Barr virus-associated gastric cancer; DFS: Disease-free survival; RFS: Recurrence-free survival; G: Gastric cancer; CSS: Cancer-specific survival; OS: Overall-survival.

Citation: Kang BW, Kim JG, Lee IH, Bae HI, Seo AN. Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology. World J Gastrointest Oncol 2017; 9(7): 293-299
URL: https://www.wjgnet.com/1948-5204/full/v9/i7/293.htm
DOI: https://dx.doi.org/10.4251/wjgo.v9.i7.293